Intellia Therapeutics Inc buy Barclays PLC
Start price
04.08.23
/
50%
€36.00
Target price
04.08.24
€81.52
Performance (%)
-36.11%
Price
10:30
€23.00
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC for Intellia Therapeutics Inc is performing very badly with a performance of -36.11%. This prediction currently runs until 04.08.24. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | -5.095% | -5.095% |
iShares Core DAX® | -0.205% | 2.528% |
iShares Nasdaq 100 | 1.613% | 4.733% |
iShares Nikkei 225® | -0.740% | 0.396% |
iShares S&P 500 | 0.267% | 2.720% |
Comments by Barclays_PLC for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Barclays PLC from $148.00 to $90.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat